Development of a pharmacovigilance safety monitoring tool for the rollout of single low-dose primaquine and artemether-lumefantrine to treat Plasmodium falciparum infections in Swaziland: a pilot study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2875
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Development of a pharmacovigilance safety monitoring tool for the rollout of single low-dose primaquine and artemether-lumefantrine to treat Plasmodium falciparum infections in Swaziland: a pilot study ; volume:15 ; number:1 ; day:22 ; month:7 ; year:2016 ; pages:1-12 ; date:12.2016
Malaria journal ; 15, Heft 1 (22.7.2016), 1-12, 12.2016
- Urheber
-
Poirot, Eugenie
- Beteiligte Personen und Organisationen
-
Soble, Adam
Ntshalintshali, Nyasatu
Mwandemele, Asen
Mkhonta, Nomcebo
Malambe, Calisile
Vilakati, Sibonakaliso
Pan, Sisi
Darteh, Sarah
Maphalala, Gugu
Brown, Joelle
Hwang, Jimee
Pace, Cheryl
Stergachis, Andy
Vittinghoff, Eric
Kunene, Simon
Gosling, Roland
SpringerLink (Online service)
- DOI
-
10.1186/s12936-016-1410-7
- URN
-
urn:nbn:de:1111-201607256819
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:01 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Poirot, Eugenie
- Soble, Adam
- Ntshalintshali, Nyasatu
- Mwandemele, Asen
- Mkhonta, Nomcebo
- Malambe, Calisile
- Vilakati, Sibonakaliso
- Pan, Sisi
- Darteh, Sarah
- Maphalala, Gugu
- Brown, Joelle
- Hwang, Jimee
- Pace, Cheryl
- Stergachis, Andy
- Vittinghoff, Eric
- Kunene, Simon
- Gosling, Roland
- SpringerLink (Online service)
Ähnliche Objekte (12)
Optimal timing of primaquine to reduce Plasmodium falciparum gametocyte carriage when co-administered with artemether–lumefantrine
Development of a dissolution method for lumefantrine and artemether in immediate release fixed dose artemether/lumefantrine tablets
The clinical efficacy of artemether/lumefantrine (Coartem®)
Pharmacokinetics of artemether and dihydroartemisinin in healthy Pakistani male volunteers treated with artemether-lumefantrine
Artemether-lumefantrine efficacy among adults on antiretroviral therapy in Malawi
Malaria case-management under artemether-lumefantrine treatment policy in Uganda
Does artemether–lumefantrine administration affect mosquito olfactory behaviour and fitness?
Pharmacopeial quality of artemether–lumefantrine anti-malarial agents in Uganda
Adverse reaction to Coartem (artemether/lumefantrine) resulting in oculogyric crisis
Investigations on the neurotoxic effects of the anti-malaria components artemether and artemether-lumefantrine in dogs
Safety of a single low-dose of primaquine in addition to standard artemether-lumefantrine regimen for treatment of acute uncomplicated Plasmodium falciparum malaria in Tanzania
Mass campaigns with antimalarial drugs: a modelling comparison of artemether-lumefantrine and DHA-piperaquine with and without primaquine as tools for malaria control and elimination
Optimal timing of primaquine to reduce Plasmodium falciparum gametocyte carriage when co-administered with artemether–lumefantrine
Development of a dissolution method for lumefantrine and artemether in immediate release fixed dose artemether/lumefantrine tablets
The clinical efficacy of artemether/lumefantrine (Coartem®)
Pharmacokinetics of artemether and dihydroartemisinin in healthy Pakistani male volunteers treated with artemether-lumefantrine
Artemether-lumefantrine efficacy among adults on antiretroviral therapy in Malawi
Malaria case-management under artemether-lumefantrine treatment policy in Uganda
Does artemether–lumefantrine administration affect mosquito olfactory behaviour and fitness?
Pharmacopeial quality of artemether–lumefantrine anti-malarial agents in Uganda
Adverse reaction to Coartem (artemether/lumefantrine) resulting in oculogyric crisis
Investigations on the neurotoxic effects of the anti-malaria components artemether and artemether-lumefantrine in dogs
Safety of a single low-dose of primaquine in addition to standard artemether-lumefantrine regimen for treatment of acute uncomplicated Plasmodium falciparum malaria in Tanzania
Mass campaigns with antimalarial drugs: a modelling comparison of artemether-lumefantrine and DHA-piperaquine with and without primaquine as tools for malaria control and elimination
Optimal timing of primaquine to reduce Plasmodium falciparum gametocyte carriage when co-administered with artemether–lumefantrine
Development of a dissolution method for lumefantrine and artemether in immediate release fixed dose artemether/lumefantrine tablets
The clinical efficacy of artemether/lumefantrine (Coartem®)
Pharmacokinetics of artemether and dihydroartemisinin in healthy Pakistani male volunteers treated with artemether-lumefantrine
Artemether-lumefantrine efficacy among adults on antiretroviral therapy in Malawi
Malaria case-management under artemether-lumefantrine treatment policy in Uganda
Does artemether–lumefantrine administration affect mosquito olfactory behaviour and fitness?
Pharmacopeial quality of artemether–lumefantrine anti-malarial agents in Uganda
Adverse reaction to Coartem (artemether/lumefantrine) resulting in oculogyric crisis
Investigations on the neurotoxic effects of the anti-malaria components artemether and artemether-lumefantrine in dogs
Safety of a single low-dose of primaquine in addition to standard artemether-lumefantrine regimen for treatment of acute uncomplicated Plasmodium falciparum malaria in Tanzania